Drug Chatter -- Tracking biopharma stock chatter

Profile for Five Prime Therapeutics, Inc. (FPRX)

« Back to company index

FPRX Chatter Timeline

Stock Ticker for FPRX

Most Active Tweeters for FPRX

UserTweets
@TickerReport 7
@SPNewsAnalysis 5
@emq_news 5
@chaffeybreeze 3
@intercooleronli 3

Recent Tweets for FPRX

JasonHolman5 @JasonHolman5
Imagine the v. low ORR doesn't bode well for $FPRX, FPA008. https://t.co/YY3mx0lNAh
July 24th 2017, 6:07pm
WarrenofWallSt @WarrenofWallSt
Traditional fundamentals don't apply to Biotechs like #FivePrimeTherapeutics $FPRX https://t.co/ngo1kcFMVt https://t.co/gCsvgJmWPw
July 23rd 2017, 10:07am
dailymailtimes @dailymailtimes
Brokerages Set Five Prime Therapeutics, Inc. $FPRX Target Price at $65.20 https://t.co/ib90UHia9x
July 22nd 2017, 7:07pm
IRAMarketReport @IRAMarketReport
Teachers Retirement System of The State of Kentucky Has $866,000 Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/LWVwc97ag2
July 22nd 2017, 10:07am
chaffeybreeze @chaffeybreeze
Teachers Retirement System of The State of Kentucky Has $866,000 Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/oE8kUUKh2P
July 22nd 2017, 10:07am
emq_news @emq_news
Five Prime Therapeutics, Inc. $FPRX Shares Sold by TIAA CREF Investment Management LLC https://t.co/Mf1OkTpZKL
July 22nd 2017, 9:07am
chaffeybreeze @chaffeybreeze
TIAA CREF Investment Management LLC Reduces Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/MQwf5bAA7P
July 22nd 2017, 9:07am
IRAMarketReport @IRAMarketReport
TIAA CREF Investment Management LLC Reduces Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/yZLh6bwUGw
July 22nd 2017, 8:07am
wulamkam @wulamkam
$fprx consolidation pattern /shows sign of accumulation https://t.co/5xsTJBxI0Q
July 22nd 2017, 7:07am
portefeuillefun @portefeuillefun
Sold 800 $FPRX at $30.21, now 800 #vssporte shares.
July 21st 2017, 11:07am
emq_news @emq_news
Five Prime Therapeutics, Inc. $FPRX Stake Raised by Goldman Sachs Group Inc. https://t.co/LThZgM4Nek
July 21st 2017, 10:07am
TickerReport @TickerReport
Five Prime Therapeutics, Inc. $FPRX Stake Raised by Goldman Sachs Group Inc. https://t.co/VMAuI6tT37
July 21st 2017, 10:07am
emq_news @emq_news
Brokerages Anticipate Five Prime Therapeutics, Inc. $FPRX Will Post Quarterly Sales of $10.15 Million https://t.co/SRKuNMJFH2
July 20th 2017, 12:07am
TickerReport @TickerReport
Brokerages Anticipate Five Prime Therapeutics, Inc. $FPRX Will Post Quarterly Sales of $10.15 Million https://t.co/KAWQ7L5cvm
July 20th 2017, 12:07am
dakotafinancial @dakotafinancial
Five Prime Therapeutics, Inc. $FPRX Expected to Announce Quarterly Sales of $10.15 Million https://t.co/StkPXSBj5p
July 20th 2017, 12:07am
TickerReport @TickerReport
Brokerages Anticipate Five Prime Therapeutics, Inc. $FPRX Will Post Quarterly Sales of $10.15 Million https://t.co/UvH2IiE4ma
July 19th 2017, 11:07pm
1stOncology @1stOncology
First Dosing in Phase 1 Safety Trial Evaluating #FPA144 in #GastricCancer $FPRX https://t.co/W6pxhb9lx3
July 19th 2017, 12:07pm
tgtxdough @tgtxdough
WF $FPRX Expanded Development Of FPA144 To Asia Should Increase Opportunity In Gastric Cancer https://t.co/wpyrAv8sQk
July 18th 2017, 7:07am
emq_news @emq_news
Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/sDHa8uGKGu
July 17th 2017, 9:07pm
storminvestor @storminvestor
Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/c1HTVoPI86
July 17th 2017, 9:07pm
SPNewsAnalysis @SPNewsAnalysis
Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/noQLlRo0u9
July 17th 2017, 9:07pm
TickerReport @TickerReport
Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/38wO4ljQva
July 17th 2017, 9:07pm
TickerReport @TickerReport
Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/I3nNk6NyiC
July 17th 2017, 8:07pm
intercooleronli @intercooleronli
Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/teUvZzSFpF
July 17th 2017, 8:07pm
YoungChris27040 @YoungChris27040
RT @odibro: $FPRX Initiates Patient Dosing in Phase 1 Clinical Safety Trial Evaluating FPA144 in Gastric Cancer in Japan https://t.co/CYvG…
July 17th 2017, 7:07pm
Briefingcom @Briefingcom
$FPRX: Five Prime Therapeutics initiated dosing in its Phase 1 clinical trial of FPA144, an anti-FGF receptor 2b... https://t.co/uoh9S5afI6
July 17th 2017, 6:07pm
emq_news @emq_news
Five Prime Therapeutics, Inc. $FPRX Expected to Post Earnings of -$1.18 Per Share https://t.co/Gf1JfOWuOq
July 17th 2017, 5:07pm
TickerReport @TickerReport
Five Prime Therapeutics, Inc. $FPRX Expected to Post Earnings of -$1.18 Per Share https://t.co/bb9vAFjjzh
July 17th 2017, 5:07pm
SPNewsAnalysis @SPNewsAnalysis
Five Prime Therapeutics, Inc. $FPRX Expected to Post Earnings of -$1.18 Per Share https://t.co/bzjDY15N0M
July 17th 2017, 5:07pm
TickerReport @TickerReport
Five Prime Therapeutics, Inc. $FPRX Expected to Post Earnings of -$1.18 Per Share https://t.co/D7HnMUrNw8
July 17th 2017, 5:07pm
MyAlliesTrading @MyAlliesTrading
$FPRX Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Clinical Safety Trial Evaluating FPA144 in G... https://t.co/d9Vao2tQ3P
July 17th 2017, 4:07pm
stockboardinc @stockboardinc
$FPRX Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Clinical Safety Trial Evaluating FPA144 ... - https://t.co/Uzx5z8jEz7
July 17th 2017, 4:07pm
stocknewsdotcom @stocknewsdotcom
$FPRX Initiated dosing in its Phase 1 clinical trial of FPA144, an anti-FGF receptor 2b antibody, in patients with… https://t.co/MrrbZeJQW4
July 17th 2017, 4:07pm
odibro @odibro
$FPRX Initiates Patient Dosing in Phase 1 Clinical Safety Trial Evaluating FPA144 in Gastric Cancer in Japan https://t.co/CYvGsIlEfl
July 17th 2017, 4:07pm
GNWLive @GNWLive
Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Clinical Safety Trial Evaluating FPA144 in $FPRX https://t.co/sKItirOAlc
July 17th 2017, 4:07pm
portefeuillefun @portefeuillefun
Sold 400 $FPRX at $30.40, now 1600 #vssporte shares.
July 17th 2017, 11:07am
VeeDub78 @VeeDub78
I want to go long $FPRX but it's a COMPLETE gamble. I know nothing about the company, I just like buying dips.
July 17th 2017, 7:07am
SPNewsAnalysis @SPNewsAnalysis
Five Prime Therapeutics $FPRX Given News Impact Score of 0.35 https://t.co/qWv8Y80rtx
July 16th 2017, 10:07am
storminvestor @storminvestor
Five Prime Therapeutics $FPRX Given News Impact Score of 0.35 https://t.co/XV7WXH8HNZ
July 16th 2017, 10:07am
intercooleronli @intercooleronli
Five Prime Therapeutics, Inc. $FPRX Expected to Announce Quarterly Sales of $10.15 Million https://t.co/h68kSBpm0c
July 16th 2017, 8:07am
dailypoliticaln @dailypoliticaln
Five Prime Therapeutics, Inc. $FPRX Expected to Announce Quarterly Sales of $10.15 Million https://t.co/4AiihAgihy
July 16th 2017, 8:07am
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $FPRX is $-1.02 it's -3.48% of the current price https://t.co/DX86jWrkOj
July 16th 2017, 3:07am
1MinuteStock @1MinuteStock
Not sure what to do with $FPRX? Explore our #fundamental pros and cons. https://t.co/A9LtiK4Woc
July 16th 2017, 3:07am
SPNewsAnalysis @SPNewsAnalysis
Analysts Anticipate Five Prime Therapeutics, Inc. $FPRX Will Announce Earnings of -$1.18 Per Share https://t.co/akBkf1V6UP
July 15th 2017, 4:07pm
dakotafinancial @dakotafinancial
Five Prime Therapeutics, Inc. $FPRX Expected to Post Quarterly Sales of $10.15 Million https://t.co/CrHdkWqWhN
July 15th 2017, 3:07pm
dakotafinancial @dakotafinancial
Five Prime Therapeutics $FPRX Earning Positive News Coverage, Report Shows https://t.co/GwnSWZN5oM
July 14th 2017, 8:07pm
SleekMoneycom @SleekMoneycom
Five Prime Therapeutics, Inc. $FPRX Expected to Announce Earnings of -$1.18 Per Share https://t.co/LYnuYOZDxP
July 14th 2017, 4:07pm
intercooleronli @intercooleronli
Five Prime Therapeutics, Inc. $FPRX Expected to Announce Earnings of -$1.18 Per Share https://t.co/6GgFOvIMTb
July 14th 2017, 2:07pm
MarginHunt @MarginHunt
Our valuation shows 26% upside for Five Prime Therapeutics, Inc. $FPRX while @ 47% of 52week high… https://t.co/zzCeZ0cjax
July 13th 2017, 8:07pm
portefeuillefun @portefeuillefun
Sold 500 $FPRX at $30.00, now 2000 #vssporte shares.
July 13th 2017, 3:07pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.